Hiroyuki Hagiyama

Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan

Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama et al. · Annals of the Rheumatic Diseases · 2016 · 93 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial

Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani et al. · Arthritis Research & Therapy · 2017 · 54 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.

Hiroyuki Hagiyama, Takeyoshi Kubota, Yukiko Komano et al. · PubMed · 2004 · 53 citations

Medicine, Clinical Sciences, Internal Medicine +12

Efficient detection of somatic <i>UBA1</i> variants and clinical scoring system predicting patients with variants in VEXAS syndrome

Ayaka Maeda, Naomi Tsuchida, Yuri Uchiyama et al. · Lara D. Veeken · 2023 · 41 citations

Life Sciences, Genetics, Molecular Genetics +17

Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice

Tsutomu Yoshida, Tetsuya Higuchi, Hiroyuki Hagiyama et al. · International Immunology · 2000 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +17